Cellectar Biosciences, Inc. financial statements
Cellectar Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 21.79M | 10-K |
| Cash and equivalents | USD 13.2M | 10-Q |
| Total debt | USD 409.59K | EODHD |
Cellectar Biosciences, Inc. financials on 6ix · Cellectar Biosciences, Inc. on 6ix